Device for delivery of antimicrobial agent into a medical device
Inventors
Ziebol, Robert J. • Modert, Keith J.
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
A system, method, and article for delivering an antimicrobial agent into the lumen of a trans-dermal catheter are disclosed. In an embodiment, the system comprises an elongate member configured for insertion into a lumen of a catheter, and the elongate member containing an antimicrobial. An antimicrobial agent can be placed on an interior surface of a retaining ring.
Core Innovation
The claims describe an antimicrobial cap configured to disinfect a medical connector or catheter when inserted into a channel containing liquid. The cap comprises a threaded outer shroud and an elongate portion bearing a water-soluble dry antimicrobial agent. As the elongate portion enters the channel, at least some agent transfers into the liquid, and at least some liquid is displaced through the proximal opening onto the exterior surface of the connector or catheter.
Disclosed configurations include an elongate portion integral with a sealing portion, an elongate portion integrally formed with a first portion, and a separately formed proximal plate covering the proximal opening with a tapered male luer base and an elongate rod. The luer base is configured to create a fluid tight seal with the inner wall, while the threaded shroud attaches to the outside surface. The background section and its description of the problem being solved are not included in the provided content.
Claims Coverage
The independent claims are claims 1, 9, and 18. They cover three inventive features relating to antimicrobial caps configured to transfer a water-soluble dry antimicrobial agent into liquid in a medical connector or catheter and displace liquid onto its exterior.
Antimicrobial cap with an elongate portion integral with a sealing portion
Claim 1 covers an outer shroud with an interior threaded portion and an elongate portion integral with a sealing portion coupled to the shroud and extending distally beyond it. The elongate portion has a solid cross-section at its distal tip and carries a water-soluble dry antimicrobial agent on at least its outside surface. Insertion transfers at least some agent into the liquid and displaces at least some liquid through the proximal opening onto the connector or catheter exterior, while the threaded portion attaches to its outside surface.
Antimicrobial cap with an elongate portion integrally formed with a first portion
Claim 9 covers an outer shroud with an interior threaded portion and an elongate portion integrally formed with a first portion coupled to the shroud, extending distally beyond the shroud. The elongate portion has a solid cross-sectional region at its distal end and bears a water-soluble dry antimicrobial agent where configured to contact the liquid. Insertion transfers at least some agent into the liquid and displaces at least some liquid through the proximal opening onto the connector or catheter exterior.
Antimicrobial cap with a separate proximal plate and elongate rod
Claim 18 covers an outer shroud with proximal and distal openings, a separately formed proximal plate covering the proximal opening, and a tapered male luer base from which an elongate rod extends beyond the distal opening. The rod has a solid cross-section at its distal tip and carries a water-soluble dry antimicrobial agent on at least its outside surface. The luer base creates a fluid tight seal with the inner wall, while insertion transfers agent into the liquid and displaces liquid through the proximal opening onto the exterior.
The three independent claims cover antimicrobial cap structures that transfer a water-soluble dry antimicrobial agent into liquid in a medical connector or catheter, displace liquid onto its exterior, and attach via a threaded outer shroud. Claim 18 additionally specifies a separately formed proximal plate and a tapered male luer base configured to create a fluid tight seal with the inner wall.
Stated Advantages
The reported results associate ClearGuard HD with substantially lower Candida counts, including complete Candida albicans kill in tested lock-solution models.
The reported results show 100% bacteria-free catheter survival (no contamination) for the ClearGuard HD group over 26 days, whereas the standard-cap control group falls to 0% bacteria-free survival with all controls contaminated by day 14.
Documented Applications
Disinfecting a medical connector or catheter when the antimicrobial cap is inserted into a channel containing liquid in the connector or catheter.
Interested in licensing this patent?